Blood Processing Devices and Consumables Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Devices, Consumables), By Usage (Red Blood Cells, Plasma, Platelets, Others), By Region & Competition, 2021-2031F

The Global market for blood processing devices and consumables is expected to expand from USD 46.57 billion in 2025 to USD 64.32 billion by 2031, reflecting a compound annual growth rate (CAGR) of 5.53%. This industry includes the equipment and single-use products required to collect, separate, filter, and store whole blood and its distinct components. Market growth is primarily fueled by a rising number of surgical procedures, heightened awareness of blood safety measures, and a growing prevalence of chronic conditions that require regular blood transfusions. Emphasizing the sheer scale of annual processing needs, the AABB National Blood Collection and Utilization Survey reported that 11.58 million units of red blood cells were gathered in the United States in 2023.

A major obstacle hindering the expansion of this market is the strict and constantly changing regulatory landscape for medical devices and blood products worldwide. Navigating these complex rules requires substantial financial commitments for compliance, which can ultimately drive up operational costs across the sector and postpone the introduction of new products.

Market Driver

The Global market for blood processing devices and consumables is heavily driven by the increasing rates of infectious and chronic illnesses, which elevate the need for blood components in both therapeutic and diagnostic settings. Severe infections, autoimmune diseases, and various forms of cancer frequently require plasma-derived therapies or direct blood transfusions. Highlighting the vast number of patients who might need such interventions, the World Health Organization reports that noncommunicable diseases account for 74% of global fatalities. This ongoing requirement for blood products ensures a steady reliance on sophisticated processing equipment capable of safely and effectively preparing various blood components for medical use.

Another major growth catalyst is the rapid technological advancement in the storage and processing of blood, which spurs the creation of innovative consumables and devices that improve component quality, safety, and operational efficiency. These breakthroughs feature advanced storage methods that preserve product integrity and lengthen shelf life, enhanced filtration systems, and automated blood separation technologies. Demonstrating the value of automation, Terumo Blood and Cell Technologies noted that their Reveos(TM) Automated Blood Processing System, introduced to the U.S. market in October 2024, cuts manual whole blood separation tasks by up to 65%. These cutting-edge solutions are vital for addressing the intricate needs of today's healthcare landscape, especially given that The Global Plasma Economy valued plasma and its derivatives at USD 35.8 billion globally in 2024.

Market Challenge

The rigorous and continuously shifting global regulatory framework acts as a major barrier to the expansion of the blood processing devices and consumables market. Complying with varied and regularly revised rules across different countries requires significant investments of both operational resources and financial capital. The difficulty of managing these complex approval processes not only extends the time required for product development and launch but also forms substantial hurdles for smaller, innovative companies trying to enter the market.

This intricate regulatory landscape slows industry growth by holding up the release of crucial new technologies for the storage, filtration, separation, and collection of blood. Highlighting this delay, the 2024 MedTech Europe IVDR & MDR Survey Results indicated that medical device producers faced an average wait of 21.8 months to finish the Technical Documentation Assessment (TDA) needed for European CE-marking. Such prolonged timelines lead to higher research and development expenses, postponed income, and an overall reduction in the speed at which innovative products become available in this vital sector.

Market Trends

The shift toward mobility and decentralization in blood processing and collection is significantly transforming the market by moving these activities outside of conventional clinical and hospital environments. This movement is fueled by the need for quicker response times, enhanced convenience, and better accessibility, especially for remote medical care and emergencies. Key developments enabling this transition include prehospital transfusion initiatives that bring blood directly to patients and mobile donation facilities; a May 2025 report from America's Blood Centers noted that community centers offering prehospital blood products grew from 18 in 2022 to 34 in 2024. Consequently, there is a growing need for portable, specialized storage and processing equipment that can operate effectively in varied settings.

Another prominent trend altering the industry is the rise of minimally invasive, patient-focused blood collection tools designed to improve the overall experience for patients and donors. These advancements seek to alleviate the discomfort, stress, and potential complications linked to standard venipuncture procedures. Solutions like needle-free options, capillary collection systems, and micro-sampling tools are becoming increasingly popular, particularly for individuals needing regular blood tests or those in sensitive demographic groups, as they utilize less blood without sacrificing diagnostic precision. Illustrating this preference, a May 2025 announcement by Ash titled "From Finger Prick to One Click: Ash Launches Tasso Blood Collection Device" reported that more than 95% of users favored the Tasso system over traditional collection techniques, a shift that is directly guiding the creation and use of modern processing consumables.

Key Market Players

• Beckman Coulter, Inc.
• Haemonetics Corporation
• Maco Pharma International GmbH
• Poly Medicure Ltd.
• Immucor, Inc.
• Fresenius SE & Co KGaA
• Neomedic Limited
• Global Scientific Company
• Sigma Laborzentrifugen GmbH
• Terumo BCT, Inc.

Report Scope

In this report, the Global Blood Processing Devices and Consumables Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Processing Devices and Consumables Market, By Product

• Devices
• Consumables

Blood Processing Devices and Consumables Market, By Usage

• Red Blood Cells
• Plasma
• Platelets
• Others

Blood Processing Devices and Consumables Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Processing Devices and Consumables Market.

Available Customizations:

Global Blood Processing Devices and Consumables Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).